196 related articles for article (PubMed ID: 19533046)
1. Performance characteristics of a sliding-scale hypertonic saline infusion protocol for the treatment of acute neurologic hyponatremia.
Woo CH; Rao VA; Sheridan W; Flint AC
Neurocrit Care; 2009; 11(2):228-34. PubMed ID: 19533046
[TBL] [Abstract][Full Text] [Related]
2. Administration of hypertonic (3%) sodium chloride/acetate in hyponatremic patients with symptomatic vasospasm following subarachnoid hemorrhage.
Suarez JI; Qureshi AI; Parekh PD; Razumovsky A; Tamargo RJ; Bhardwaj A; Ulatowski JA
J Neurosurg Anesthesiol; 1999 Jul; 11(3):178-84. PubMed ID: 10414672
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Desmopressin in Critically Ill Patients with Hyponatremia Requiring 3% Hypertonic Saline.
Tran LK; Marino KK; DeGrado JR; Szumita PM; Dube KM
Am J Med Sci; 2021 Jun; 361(6):711-717. PubMed ID: 33812910
[TBL] [Abstract][Full Text] [Related]
4. Treatment of symptomatic hyponatremia with hypertonic saline: a real-life observational study.
Chifu I; Gerstl A; Lengenfelder B; Schmitt D; Nagler N; Fassnacht M; Weismann D
Eur J Endocrinol; 2021 May; 184(5):647-655. PubMed ID: 33635825
[TBL] [Abstract][Full Text] [Related]
5. Hypertonic saline for hyponatremia: risk of inadvertent overcorrection.
Mohmand HK; Issa D; Ahmad Z; Cappuccio JD; Kouides RW; Sterns RH
Clin J Am Soc Nephrol; 2007 Nov; 2(6):1110-7. PubMed ID: 17913972
[TBL] [Abstract][Full Text] [Related]
6. Hypertonic saline: patterns of and guidelines for use.
Culpepper RM; Clements BD; Pence SR
South Med J; 1994 Dec; 87(12):1203-7. PubMed ID: 7973918
[TBL] [Abstract][Full Text] [Related]
7. Hypertonic saline and desmopressin: a simple strategy for safe correction of severe hyponatremia.
Sood L; Sterns RH; Hix JK; Silver SM; Chen L
Am J Kidney Dis; 2013 Apr; 61(4):571-8. PubMed ID: 23266328
[TBL] [Abstract][Full Text] [Related]
8. Continuous Versus Bolus Infusion of Hypertonic Saline in the Treatment of Symptomatic Hyponatremia Caused by SIAD.
Garrahy A; Dineen R; Hannon AM; Cuesta M; Tormey W; Sherlock M; Thompson CJ
J Clin Endocrinol Metab; 2019 Sep; 104(9):3595-3602. PubMed ID: 30882872
[TBL] [Abstract][Full Text] [Related]
9. Rapid correction of severe hyponatremia with intravenous hypertonic saline solution.
Ayus JC; Olivero JJ; Frommer JP
Am J Med; 1982 Jan; 72(1):43-8. PubMed ID: 7058821
[TBL] [Abstract][Full Text] [Related]
10. Treatment of Hyponatremia in Patients with Acute Neurological Injury.
Human T; Cook AM; Anger B; Bledsoe K; Castle A; Deen D; Gibbs H; Lesch C; Liang N; McAllen K; Morrison C; Parker D; Rowe AS; Rhoney D; Sangha K; Santayana E; Taylor S; Tesoro E; Brophy G
Neurocrit Care; 2017 Oct; 27(2):242-248. PubMed ID: 28054290
[TBL] [Abstract][Full Text] [Related]
11. Prevention of brain demyelination in rats after excessive correction of chronic hyponatremia by serum sodium lowering.
Soupart A; Penninckx R; Crenier L; Stenuit A; Perier O; Decaux G
Kidney Int; 1994 Jan; 45(1):193-200. PubMed ID: 8127009
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of rapid intermittent correction compared with slow continuous correction with hypertonic saline in patients with moderately severe or severe symptomatic hyponatremia: study protocol for a randomized controlled trial (SALSA trial).
Lee A; Jo YH; Kim K; Ahn S; Oh YK; Lee H; Shin J; Chin HJ; Na KY; Lee JB; Baek SH; Kim S
Trials; 2017 Mar; 18(1):147. PubMed ID: 28356136
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of a protocol for hypertonic saline administration in acute euvolemic symptomatic hyponatremia: A prospective observational trial.
Bhaskar E; Kumar B; Ramalakshmi S
Indian J Crit Care Med; 2010 Oct; 14(4):170-4. PubMed ID: 21572746
[TBL] [Abstract][Full Text] [Related]
14. Risk of Overcorrection in Rapid Intermittent Bolus vs Slow Continuous Infusion Therapies of Hypertonic Saline for Patients With Symptomatic Hyponatremia: The SALSA Randomized Clinical Trial.
Baek SH; Jo YH; Ahn S; Medina-Liabres K; Oh YK; Lee JB; Kim S
JAMA Intern Med; 2021 Jan; 181(1):81-92. PubMed ID: 33104189
[TBL] [Abstract][Full Text] [Related]
15. Hypertonic saline (7.2%) in 6% hydroxyethyl starch reduces intracranial pressure and improves hemodynamics in a placebo-controlled study involving stable patients with subarachnoid hemorrhage.
Bentsen G; Breivik H; Lundar T; Stubhaug A
Crit Care Med; 2006 Dec; 34(12):2912-7. PubMed ID: 17075367
[TBL] [Abstract][Full Text] [Related]
16. Treatment of symptomatic hyponatremia.
Decaux G; Soupart A
Am J Med Sci; 2003 Jul; 326(1):25-30. PubMed ID: 12861122
[TBL] [Abstract][Full Text] [Related]
17. Treatment of Hyponatremic Encephalopathy in the Critically Ill.
Achinger SG; Ayus JC
Crit Care Med; 2017 Oct; 45(10):1762-1771. PubMed ID: 28704229
[TBL] [Abstract][Full Text] [Related]
18. Effect of hypertonic saline on cerebral blood flow in poor-grade patients with subarachnoid hemorrhage.
Tseng MY; Al-Rawi PG; Pickard JD; Rasulo FA; Kirkpatrick PJ
Stroke; 2003 Jun; 34(6):1389-96. PubMed ID: 12730557
[TBL] [Abstract][Full Text] [Related]
19. Hypertonic saline solution for renal failure prevention in patients with decompensated heart failure.
Issa VS; Bacal F; Mangini S; Carneiro RM; Azevedo CH; Chizzola PR; Ferreira SM; Bocchi EA
Arq Bras Cardiol; 2007 Oct; 89(4):251-5. PubMed ID: 17992382
[TBL] [Abstract][Full Text] [Related]
20. Complications associated with prolonged hypertonic saline therapy in children with elevated intracranial pressure.
Gonda DD; Meltzer HS; Crawford JR; Hilfiker ML; Shellington DK; Peterson BM; Levy ML
Pediatr Crit Care Med; 2013 Jul; 14(6):610-20. PubMed ID: 23823197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
